G
Naval Medical Logistics Command on behalf of the Naval Medical Research Center is requesting information from contractors capable of conducting a non-human primate (NHP) study using a dengue tetravalent purified inactivated vaccine (TPIV) with a novel adjuvant, and then challenge non-human primates (NHPs) with wild type viruses to evaluate enhanced immunogenicity and efficacy.